Pharma and BioTech Daily
By Pharma and BioTech News
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Pharma and BioTech News
Category: Tech News
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 6
Reviews: 0
Episodes: 64
Description
Pharma & Biotech Daily is a short, AI-generated, human-supervised briefing on what’s important in pharma and biotech.
Each weekday we condense key news on pipelines, deals, regulation and strategy into a quick audio update for people who build, run and invest in life sciences.
Produced by OWITH.ai, a boutique AI & data studio.
Sponsor the show: https://sponsor.owith.ai
| Episode | Date |
|---|---|
|
Pfizer CEO Rethinks Germany Investments Amid Reform Concerns | Pharma and Biotech Daily
|
Jun 11, 2026 |
|
Merck & Gilead's HIV Pill Breakthrough: Phase 3 Success! | Pharma and Biotech Daily
|
Jun 10, 2026 |
|
Eli Lilly's Retatrutide Breakthrough: 30.3% Weight Loss Success | Pharma and Biotech Daily
|
Jun 09, 2026 |
|
Pfizer & Chai AI Breakthrough: $1.675B Gilead Deal | Pharma and Biotech Daily
|
Jun 08, 2026 |
|
Eli Lilly & Boehringer Cut $1B+ Investments in Germany | Pharma and Biotech Daily
|
Jun 05, 2026 |
|
Legend Biotech's CAR T-Cell Breakthrough: 100% Response Rate | Pharma and Biotech Daily
|
Jun 04, 2026 |
|
Moderna-Merck Combo Cuts Melanoma Risk by 49% | Pharma and Biotech Daily
|
Jun 03, 2026 |
|
Akeso's Ivonescimab Shows 34% Death Risk Cut at ASCO | Pharma and Biotech Daily
|
Jun 02, 2026 |
|
Pfizer's $10B Innovent Deal Boosts Cancer Drugs | Pharma and Biotech Daily
|
Jun 01, 2026 |
|
Eli Lilly's Zepbound Coverage Restored! Breaking News | Pharma and Biotech Daily
|
May 29, 2026 |
|
Outlook Therapeutics Wins FDA Appeal for $1.3B Deal | Pharma and Biotech Daily
|
May 28, 2026 |
|
Gilead's Hepcludex FDA Approval Marks Milestone | Pharma and Biotech Daily
|
May 27, 2026 |
|
Lilly's Obesity Drug Rivals Surgery: FDA Changes Ahead | Pharma and Biotech Daily
|
May 26, 2026 |
|
AstraZeneca's Datroway FDA Approved for TNBC | Pharma and Biotech Daily
|
May 25, 2026 |
|
Eli Lilly's $1B Novo Nordisk Deal: Diabetes Focus | Pharma and Biotech Daily
|
May 22, 2026 |
|
Pfizer Leads Pneumococcal Vaccine Efforts | Pharma and Biotech Daily
|
May 21, 2026 |
|
Takeda Faces $885M Verdict in Antitrust Case | Pharma and Biotech Daily
|
May 20, 2026 |
|
Regeneron $2.3B Deal & FDA Shake-Up | Pharma and Biotech Daily
|
May 19, 2026 |
|
Eisai's Leqembi Forecasts $900M Sales Boost | Pharma and Biotech Daily
|
May 18, 2026 |
|
Beone's Beqalzi FDA Approval Challenges AbbVie | Pharma and Biotech Daily
|
May 15, 2026 |
|
Takeda Lays Off 4,500 | FDA Leadership Change News | Pharma and Biotech Daily
|
May 14, 2026 |
|
Pfizer's $85M Breast Cancer Deal & FDA Shakeup | Pharma and Biotech Daily
|
May 13, 2026 |
|
Daiichi Sankyo's $1.3B Oncology Plan & CSL's $5B Setback | Pharma and Biotech Daily
|
May 12, 2026 |
|
Gilead Projects $1B YezTugo Sales | Pharma and Biotech Daily
|
May 11, 2026 |
|
Roche Acquires PathAI for $1B: AI-Driven Diagnostics Revolution | Pharma and Biotech Daily
|
May 08, 2026 |
|
Bayer's $2.4B Perfuse Deal Shakes Up Eye Care | Pharma and Biotech Daily
|
May 07, 2026 |
|
Sanofi Invests $294M in AI, FDA Approves Auvelity | Pharma and Biotech Daily
|
May 06, 2026 |
|
Pfizer's $300M Biologics Boost & FDA's Veppanu Approval | Pharma and Biotech Daily
|
May 05, 2026 |
|
AstraZeneca's $5B Setback: FDA Rejects New Cancer Drug | Pharma and Biotech Daily
|
May 04, 2026 |
|
Novartis' $23B U.S. Investment Boosts Pharma Manufacturing | Pharma and Biotech Daily
|
May 01, 2026 |
|
AstraZeneca's £300M UK Investment Resumes Amid FDA Pilot | Pharma and Biotech Daily
|
Apr 30, 2026 |
|
AstraZeneca's Breztri Asthma Approval Boosts $80B Goal | Pharma and Biotech Daily
|
Apr 29, 2026 |
|
Sun Pharma's $11.75B Organon Deal: Industry Shockwave | Pharma and Biotech Daily
|
Apr 28, 2026 |
|
Merck Unveils PD-1xVEGF Data, Delays Phase 3 Plans | Pharma and Biotech Daily
|
Apr 27, 2026 |
|
Regeneron Gene Therapy Approved by FDA: A Game-Changer! | Pharma and Biotech Daily
|
Apr 24, 2026 |
|
Amneal's $1.1B Biosimilars Move & Merck's HIV Pill | Pharma and Biotech Daily
|
Apr 23, 2026 |
|
Merck Welireg Fails, Roche Enspryng Shines in Trials | Pharma and Biotech Daily
|
Apr 22, 2026 |
|
Eli Lilly's $7B Kelonia Buy Boosts CAR-T Tech | Pharma and Biotech Daily
|
Apr 21, 2026 |
|
Kailera IPO Raises $625M for Obesity Drug | Pharma and Biotech Daily
|
Apr 20, 2026 |
|
Gene Therapy Setbacks and Strategic Shifts in Biotech
|
Apr 17, 2026 |
|
AI Integration and Regulatory Shifts in Pharma
|
Apr 16, 2026 |
|
AI Integration, FDA Milestones, and Strategic Shifts: Navigating Pharma's Future
|
Apr 15, 2026 |
|
Radiopharmaceuticals to CAR-T: Pharma's Cutting-Edge Advances
|
Apr 14, 2026 |
|
Biopunk Revolution: Reshaping Biotech Innovation
|
Apr 13, 2026 |
|
Revolutionizing Pharma: Key Innovations and Strategic Shifts
|
Apr 10, 2026 |
|
Navigating Breakthroughs: Pharma's Evolution in Innovation and Strategy
|
Apr 09, 2026 |
|
FDA's New Agenda & Gilead's Oncology Leap
|
Apr 08, 2026 |
|
Pharma's Future: Mergers, Innovation, and AI
|
Apr 07, 2026 |
|
Navigating Biopharma's Strategic Shift: Key Developments
|
Apr 06, 2026 |
|
Immunotherapy Breakthroughs and Regulatory Shifts in Pharma
|
Apr 03, 2026 |
|
Oral GLP-1 Breakthroughs and Strategic Biotech Shifts
|
Apr 02, 2026 |
|
Pharma Giants Transforming Through Strategic Acquisitions and AI
|
Apr 01, 2026 |
|
Biogen's SMA Breakthrough and AI's Rise in Pharma
|
Mar 31, 2026 |
|
Breakthroughs in COPD, CAR-T, and Gene Therapy
|
Mar 30, 2026 |
|
Transformative FDA Approvals and Biotech Innovations
|
Mar 27, 2026 |
|
Strategic Shifts and Breakthroughs in Pharma Innovation
|
Mar 26, 2026 |
|
Pharma 2025: Innovation Amidst Legal and Market Shifts
|
Mar 25, 2026 |
|
Navigating Pharma's Future: Key Innovations and Regulatory Shifts
|
Mar 24, 2026 |
|
Breakthroughs in Obesity and Oncology: Key Industry Shifts
|
Mar 23, 2026 |
|
Exploring Breakthroughs in Cell Therapy and Prostate Cancer
|
Mar 20, 2026 |
|
Revolutionizing Therapies: Psoriasis Breakthroughs and Biosimilar Expansion
|
Mar 19, 2026 |
|
AI Advances and Regulatory Shifts: Biopharma's New Frontier
|
Mar 18, 2026 |
|
Transformative Trials and Strategic Shifts in Pharma
|
Mar 17, 2026 |
|
Navigating Breakthroughs and Challenges in Pharma: RSV, HIV, and Neurotech
|
Mar 16, 2026 |